Convertible Notes Payable (Details) (USD $)	1 Months Ended	9 Months Ended
	Feb. 28, 2011	Sep. 30, 2013	Feb. 10, 2013	Dec. 31, 2012	Feb. 09, 2011
Convertible Notes Payable (Textual)
Units sold under private placement	6,669,627
Principal amount of convertible note issued per unit	1.15
Interest rate on convertible note payable, paid semi-annually					8.00%
Exercise price of warrant	$ 1.40
Fair value of convertible notes		$ 7,509,232
Convertible notes converted in common shares		500,000
Percentage of convertible notes converted into common stock					75.00%
Debt conversion into common stock price					$ 1.15
Released from investor relations escrow account			229,018
Escrow payment of accrued interest to investors			68,178
Escrow payment of principal to investors			160,839
Promissory note principle periodic payment		1,000,000
Note outstanding principle payment term		According to the Amendment, if the Company fails to make payment and does not cure within 45 days, interest on the then outstanding principal balance shall accrue at 8% per annum retroactively from the then missed payment date.
Promissory notes interest amount		50,000
Note outstanding principle interest rate		8.00%
Registration delay payments		460,206		460,206
Debt conversion description		According to the Amendment, if the Company fails to make a principal payment and does not cure such breach within 45 days, another 500,000 shares shall be immediately issued to note holders.
Book value of notes		7,509,232		7,267,677
Private placement [Member]
Convertible Notes Payable (Textual)
Number of common stock in exchange of warrant	1
Fair value of convertible notes					7,670,071
Convertible note expiration period	24 months
Convertible notes converted in common shares	6,669,627
Percentage of convertible notes converted into common stock					0.00%
Installment of interest payable on convertible debt	One semi-annual
Notes payable, default and affirmative and negative covenants	(i) incur, or permit to exist, any indebtedness for borrowed money in excess of (A) US$3,000,000 during the twelve (12) month period beginning on February 9, 2011, or (B) US$5,000,000 during the two-year period beginning on February 9, 2011 and ending on February 9, 2013 (the maturity date of the Notes), except in the ordinary course of the Company''s business; (ii) lend or advance money, credit or property to or invest in (by capital contribution, loan, purchase or otherwise) any person or entity in excess of US$1,000,000 except: (A) investments in United States Government obligations, certificates of deposit of any banking institution with combined capital and surplus of at least $200,000,000; (B) accounts receivable arising out of sales in the ordinary course of business; and (C) inter-company loans between and among the Company and its subsidiaries; (iii) pay dividends or make any other distribution on shares of the capital stock of the Company; (iv) create, assume or permit to exist, any lien on any of the Company''s property or assets now owned or hereafter acquired, subject to existing liens and certain exceptions; (v) assume guarantees, subject to certain exceptions; (vi) engage in "sale-leaseback" transactions, subject to certain exceptions; (vii) make capital expenditures in excess of US$5,000,000 in any fiscal year, subject to certain exceptions; and (viii) materially alter the Company''s business.
Maximum amount of indebtedness for borrowed money allowed under twelve (12) month period					3,000,000
Period of indebtedness for borrowed money allowed under condition one	12 months
Maximum amount of indebtedness for borrowed money allowed under two-year period					5,000,000
Period of indebtedness for borrowed money allowed under condition two	2 years
Convertible note issuance date	Feb. 09, 2011
Convertible notes expiration date	Feb. 09, 2013
Maximum allowed lending amount under covenants					1,000,000
Exception of leading amount in negative covenants	(A) investments in United States Government obligations, certificates of deposit of any banking institution with combined capital and surplus of at least $200,000,000
Maximum allowed capital expenditures in any fiscal year					5,000,000
Last date of filing registration rights agreement	Apr. 11, 2011
Last effective date of registration rights agreement	Sep. 18, 2011
Remedies for failure in filling registration rights agreement	The Company is required to pay an amount in cash equal to 1% of the aggregate purchase price paid by the Investors on each of the following dates: (i) 20 days following the date of a Filing Failure; (ii) 30 days following the initial day of a Maintenance Failure; (iii) on every thirtieth day thereafter (pro-rated for periods totaling less than thirty days) until such failure is cured; (iv) on every thirtieth day after the day of an Effectiveness Failure and thereafter (pro rated for periods totaling less than thirty days) until such Effectiveness Failure is cured; (v) on every thirtieth day after the initial day of a Maintenance Failure and thereafter (pro rated for periods totaling less than thirty days) until such Maintenance Failure is cured. The payments to be made by the Company are limited to a maximum of 6% of the aggregate amount paid by the Investors ($460,204.29). The registration statement was not declared effective by December 31, 2011, as such an Effectiveness Failure occurred
Percentage of aggregate purchase price of notes to be paid in case of failure	1.00%
Percentage of aggregate amount proceeds by investors to be paid in-case of failure in filling registration rights agreement	6.00%
Aggregate proceeds by investors	460,204
Amount paid for damages due to failure in declaration of effective date	460,204
Beneficial conversion feature of convertible notes	2,824,350
Private placement [Member] | Warrant [Member]
Convertible Notes Payable (Textual)
Assumed expected life for fair value calculation	3 years
Assumptions expected volatility rate for fair value calculation	100.00%
Assumed exercise price for fair value calculation					$ 1.40
Assumed dividend rate for fair value calculation	0.00%
Fair value inputs, discount rate	1.34%
Expected fair value of stock as of grant date for fair value calculation					$ 1.15
Calculated fair value of warrant					$ 4,470,536